Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 89,093 |
|
|||||
| News | - | ||||||
| Day High | 396.35 | Low High |
|||||
| Day Low | 392.50 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.1121 | 0.03% | 396.3121 | 10:18:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 396.20 | 392.50 | 396.35 | 396.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,519 | 89,093 | $ 395.24 | $ 35,213,304 | - | 320.01 - 448.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:18:33 | 5 | $ 396.19 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 102.34B | 258.31M | - | 9.92B | 3.57B | 13.82 | 28.66 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 404.00 | 406.86 | 392.50 | 400.01 | 790,119 | -7.69 | -1.90% |
| 1 Month | 419.00 | 420.87 | 391.01 | 399.81 | 935,265 | -22.69 | -5.41% |
| 3 Months | 428.76 | 437.00 | 391.01 | 413.00 | 1,088,992 | -32.45 | -7.57% |
| 6 Months | 357.15 | 448.40 | 341.90 | 401.93 | 1,322,994 | 39.16 | 10.97% |
| 1 Year | 340.22 | 448.40 | 320.01 | 377.15 | 1,224,068 | 56.09 | 16.49% |
| 3 Years | 213.71 | 448.40 | 176.36 | 281.72 | 1,506,692 | 182.60 | 85.44% |
| 5 Years | 173.93 | 448.40 | 164.07 | 258.62 | 1,542,851 | 222.38 | 127.86% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
